Ephedrae herba stimulates hepatocyte growth factor-induced MET endocytosis and downregulation via early/late endocytic pathways in gefitinib-resistant human lung cancer cells

The MET tyrosine kinase receptor and its ligand, hepatocyte growth factor (HGF), are known to be over-expressed in a variety of malignant tumor cells, and are implicated in the development of gefitinib-resistance in human non-small cell lung cancer (NSCLC) cells. Ephedrae herba was previously report...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of oncology 2016-05, Vol.48 (5), p.1895-1906
Hauptverfasser: NISHIMURA, YUKIO, HYUGA, SUMIKO, TAKIGUCHI, SOICHI, HYUGA, MASASHI, ITOH, KAZUYUKI, HANAWA, TOSHIHIKO
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1906
container_issue 5
container_start_page 1895
container_title International journal of oncology
container_volume 48
creator NISHIMURA, YUKIO
HYUGA, SUMIKO
TAKIGUCHI, SOICHI
HYUGA, MASASHI
ITOH, KAZUYUKI
HANAWA, TOSHIHIKO
description The MET tyrosine kinase receptor and its ligand, hepatocyte growth factor (HGF), are known to be over-expressed in a variety of malignant tumor cells, and are implicated in the development of gefitinib-resistance in human non-small cell lung cancer (NSCLC) cells. Ephedrae herba was previously reported to prevent HGF-induced cancer cell motility by directly suppressing HGF/MET signaling through the inhibition of MET tyrosine kinase, and treatment with its extract also considerably reduced MET protein levels. To further investigate the mechanism underlying the Ephedrae herba-induced inhibition of MET phosphorylation as well as its degradation and subsequent disappearance, we examined the effect of Ephedrae herba on HGF-stimulated MET endocytosis and downregulation via early/late endocytic pathways in an NSCLC cell line. Using immunofluorescence microscopy, we found that pretreatment of cells with Ephedrae herba extract dramatically changed the intracellular distribution of plasma membrane-associated MET, and that the resultant MET staining was distributed throughout the cytoplasm. Pretreatment of the cells with Ephedrae herba extract also led to the rapid loss of MET and phosphorylated (p)-MET in HGF-stimulated cells. In contrast, inefficient endocytic delivery of MET and p-MET from early to late endosomes was observed in the absence of Ephedrae herba extract, since considerable amounts of the internalized MET accumulated in the early endosomes and were not delivered to lysosomes up to 1 h after HGF-stimulation. Furthermore, large amounts of MET and p-MET that had accumulated in late endosomes of Ephedrae herba-pretreated cells after HGF stimulation were observed along with bafilomycin A1. Therefore, we inferred that degradation of MET occurred in the late endosome/lysosome pathway. Moreover, western blot analysis revealed the accelerated degradation of MET and p-MET proceeds in cells pretreated with Ephedrae herba extract. Collectively, our results suggest that some components of Ephedrae herba have a novel role in promoting HGF-stimulated MET and p-MET endocytosis followed by its downregulation, likely mediated by the early/late endocytic pathways.
doi_str_mv 10.3892/ijo.2016.3426
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_1932331431</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A456289618</galeid><sourcerecordid>A456289618</sourcerecordid><originalsourceid>FETCH-LOGICAL-c556t-9839cf9d1a837fa091a358373395691e8c207c9112885137067f91a6bd4b28223</originalsourceid><addsrcrecordid>eNptkktv1DAUhSMEoqWwZIssIcHKUz_ysJdVNS1IRWzKOnLsm8SjxB5sh9H8KX4jjqYtVEJe-Orqu-fq2Kco3lOy4UKyS7vzG0ZoveElq18U57SRFLOS8Ze5JlTiuuTyrHgT444QVlWEvi7OWC0FL8vmvPi93Y9gggI0QugUisnOy6QSxNzYq-T1MQEagj-kEfVKJx-wdWbRYNC37T0CZ1bERxuRcgYZf3ABhlXCeod-WYVAhel4uWo-0lajLD0e1DEi69AAvU3W2Q4HyDpJuYTGZVYOTYsbkFZOQ0Aapim-LV71aorw7uG-KH7cbO-vv-C777dfr6_usK6qOuHsTupeGqoEb3pFJFW8yiXnsqolBaEZabSklAlRUd6QuukzU3em7JhgjF8UH0-6--B_LhBTu_NLcHllSyVnnNOS07_UoCZoret9CkrPNur2qqxqJmRNRaY2_6HyMTBb7V12n_vPBj79MzCCmtIY_bSsLxqfg_gE6uBjDNC3-2BnFY4tJe2ajjano13T0a7pyPyHB1dLN4N5oh_jkIHPJyDu82da4-MTk5VwKTCpMBWy4n8AWezDWw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1932331431</pqid></control><display><type>article</type><title>Ephedrae herba stimulates hepatocyte growth factor-induced MET endocytosis and downregulation via early/late endocytic pathways in gefitinib-resistant human lung cancer cells</title><source>Spandidos Publications Journals</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>NISHIMURA, YUKIO ; HYUGA, SUMIKO ; TAKIGUCHI, SOICHI ; HYUGA, MASASHI ; ITOH, KAZUYUKI ; HANAWA, TOSHIHIKO</creator><creatorcontrib>NISHIMURA, YUKIO ; HYUGA, SUMIKO ; TAKIGUCHI, SOICHI ; HYUGA, MASASHI ; ITOH, KAZUYUKI ; HANAWA, TOSHIHIKO</creatorcontrib><description>The MET tyrosine kinase receptor and its ligand, hepatocyte growth factor (HGF), are known to be over-expressed in a variety of malignant tumor cells, and are implicated in the development of gefitinib-resistance in human non-small cell lung cancer (NSCLC) cells. Ephedrae herba was previously reported to prevent HGF-induced cancer cell motility by directly suppressing HGF/MET signaling through the inhibition of MET tyrosine kinase, and treatment with its extract also considerably reduced MET protein levels. To further investigate the mechanism underlying the Ephedrae herba-induced inhibition of MET phosphorylation as well as its degradation and subsequent disappearance, we examined the effect of Ephedrae herba on HGF-stimulated MET endocytosis and downregulation via early/late endocytic pathways in an NSCLC cell line. Using immunofluorescence microscopy, we found that pretreatment of cells with Ephedrae herba extract dramatically changed the intracellular distribution of plasma membrane-associated MET, and that the resultant MET staining was distributed throughout the cytoplasm. Pretreatment of the cells with Ephedrae herba extract also led to the rapid loss of MET and phosphorylated (p)-MET in HGF-stimulated cells. In contrast, inefficient endocytic delivery of MET and p-MET from early to late endosomes was observed in the absence of Ephedrae herba extract, since considerable amounts of the internalized MET accumulated in the early endosomes and were not delivered to lysosomes up to 1 h after HGF-stimulation. Furthermore, large amounts of MET and p-MET that had accumulated in late endosomes of Ephedrae herba-pretreated cells after HGF stimulation were observed along with bafilomycin A1. Therefore, we inferred that degradation of MET occurred in the late endosome/lysosome pathway. Moreover, western blot analysis revealed the accelerated degradation of MET and p-MET proceeds in cells pretreated with Ephedrae herba extract. Collectively, our results suggest that some components of Ephedrae herba have a novel role in promoting HGF-stimulated MET and p-MET endocytosis followed by its downregulation, likely mediated by the early/late endocytic pathways.</description><identifier>ISSN: 1019-6439</identifier><identifier>EISSN: 1791-2423</identifier><identifier>DOI: 10.3892/ijo.2016.3426</identifier><identifier>PMID: 26983447</identifier><language>eng</language><publisher>Greece: D.A. Spandidos</publisher><subject>Antineoplastic Agents, Phytogenic - pharmacology ; Breast cancer ; Carcinoma, Non-Small-Cell Lung - metabolism ; Care and treatment ; Cell Line, Tumor ; Down-Regulation - drug effects ; Drug Resistance, Neoplasm - drug effects ; endocytosis ; Endocytosis - drug effects ; endosomes/lysosomes ; Ephedra ; Ephedra - chemistry ; Ephedrae herba ; Gene amplification ; Gene expression ; Gene Expression Regulation, Neoplastic - drug effects ; Genetic aspects ; Genetic regulation ; Growth factors ; Health aspects ; hepatocyte growth factor ; Hepatocyte Growth Factor - metabolism ; Humans ; Immunoglobulins ; Inhibitor drugs ; Kinases ; Ligands ; Lung cancer ; Lung cancer, Non-small cell ; Lung Neoplasms - metabolism ; Materia medica, Vegetable ; MET ; Metastasis ; Microscopy ; Motility ; non-small cell lung cancer ; p-MET ; Phosphorylation ; Phosphorylation - drug effects ; Plant extracts ; Plant Extracts - pharmacology ; Properties ; Protein expression ; Proteins ; Proto-Oncogene Proteins c-met - metabolism ; Quinazolines - pharmacology ; Signal Transduction - drug effects ; Studies</subject><ispartof>International journal of oncology, 2016-05, Vol.48 (5), p.1895-1906</ispartof><rights>Copyright © 2016, Spandidos Publications</rights><rights>COPYRIGHT 2016 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c556t-9839cf9d1a837fa091a358373395691e8c207c9112885137067f91a6bd4b28223</citedby><cites>FETCH-LOGICAL-c556t-9839cf9d1a837fa091a358373395691e8c207c9112885137067f91a6bd4b28223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,5571,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26983447$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>NISHIMURA, YUKIO</creatorcontrib><creatorcontrib>HYUGA, SUMIKO</creatorcontrib><creatorcontrib>TAKIGUCHI, SOICHI</creatorcontrib><creatorcontrib>HYUGA, MASASHI</creatorcontrib><creatorcontrib>ITOH, KAZUYUKI</creatorcontrib><creatorcontrib>HANAWA, TOSHIHIKO</creatorcontrib><title>Ephedrae herba stimulates hepatocyte growth factor-induced MET endocytosis and downregulation via early/late endocytic pathways in gefitinib-resistant human lung cancer cells</title><title>International journal of oncology</title><addtitle>Int J Oncol</addtitle><description>The MET tyrosine kinase receptor and its ligand, hepatocyte growth factor (HGF), are known to be over-expressed in a variety of malignant tumor cells, and are implicated in the development of gefitinib-resistance in human non-small cell lung cancer (NSCLC) cells. Ephedrae herba was previously reported to prevent HGF-induced cancer cell motility by directly suppressing HGF/MET signaling through the inhibition of MET tyrosine kinase, and treatment with its extract also considerably reduced MET protein levels. To further investigate the mechanism underlying the Ephedrae herba-induced inhibition of MET phosphorylation as well as its degradation and subsequent disappearance, we examined the effect of Ephedrae herba on HGF-stimulated MET endocytosis and downregulation via early/late endocytic pathways in an NSCLC cell line. Using immunofluorescence microscopy, we found that pretreatment of cells with Ephedrae herba extract dramatically changed the intracellular distribution of plasma membrane-associated MET, and that the resultant MET staining was distributed throughout the cytoplasm. Pretreatment of the cells with Ephedrae herba extract also led to the rapid loss of MET and phosphorylated (p)-MET in HGF-stimulated cells. In contrast, inefficient endocytic delivery of MET and p-MET from early to late endosomes was observed in the absence of Ephedrae herba extract, since considerable amounts of the internalized MET accumulated in the early endosomes and were not delivered to lysosomes up to 1 h after HGF-stimulation. Furthermore, large amounts of MET and p-MET that had accumulated in late endosomes of Ephedrae herba-pretreated cells after HGF stimulation were observed along with bafilomycin A1. Therefore, we inferred that degradation of MET occurred in the late endosome/lysosome pathway. Moreover, western blot analysis revealed the accelerated degradation of MET and p-MET proceeds in cells pretreated with Ephedrae herba extract. Collectively, our results suggest that some components of Ephedrae herba have a novel role in promoting HGF-stimulated MET and p-MET endocytosis followed by its downregulation, likely mediated by the early/late endocytic pathways.</description><subject>Antineoplastic Agents, Phytogenic - pharmacology</subject><subject>Breast cancer</subject><subject>Carcinoma, Non-Small-Cell Lung - metabolism</subject><subject>Care and treatment</subject><subject>Cell Line, Tumor</subject><subject>Down-Regulation - drug effects</subject><subject>Drug Resistance, Neoplasm - drug effects</subject><subject>endocytosis</subject><subject>Endocytosis - drug effects</subject><subject>endosomes/lysosomes</subject><subject>Ephedra</subject><subject>Ephedra - chemistry</subject><subject>Ephedrae herba</subject><subject>Gene amplification</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>Genetic aspects</subject><subject>Genetic regulation</subject><subject>Growth factors</subject><subject>Health aspects</subject><subject>hepatocyte growth factor</subject><subject>Hepatocyte Growth Factor - metabolism</subject><subject>Humans</subject><subject>Immunoglobulins</subject><subject>Inhibitor drugs</subject><subject>Kinases</subject><subject>Ligands</subject><subject>Lung cancer</subject><subject>Lung cancer, Non-small cell</subject><subject>Lung Neoplasms - metabolism</subject><subject>Materia medica, Vegetable</subject><subject>MET</subject><subject>Metastasis</subject><subject>Microscopy</subject><subject>Motility</subject><subject>non-small cell lung cancer</subject><subject>p-MET</subject><subject>Phosphorylation</subject><subject>Phosphorylation - drug effects</subject><subject>Plant extracts</subject><subject>Plant Extracts - pharmacology</subject><subject>Properties</subject><subject>Protein expression</subject><subject>Proteins</subject><subject>Proto-Oncogene Proteins c-met - metabolism</subject><subject>Quinazolines - pharmacology</subject><subject>Signal Transduction - drug effects</subject><subject>Studies</subject><issn>1019-6439</issn><issn>1791-2423</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptkktv1DAUhSMEoqWwZIssIcHKUz_ysJdVNS1IRWzKOnLsm8SjxB5sh9H8KX4jjqYtVEJe-Orqu-fq2Kco3lOy4UKyS7vzG0ZoveElq18U57SRFLOS8Ze5JlTiuuTyrHgT444QVlWEvi7OWC0FL8vmvPi93Y9gggI0QugUisnOy6QSxNzYq-T1MQEagj-kEfVKJx-wdWbRYNC37T0CZ1bERxuRcgYZf3ABhlXCeod-WYVAhel4uWo-0lajLD0e1DEi69AAvU3W2Q4HyDpJuYTGZVYOTYsbkFZOQ0Aapim-LV71aorw7uG-KH7cbO-vv-C777dfr6_usK6qOuHsTupeGqoEb3pFJFW8yiXnsqolBaEZabSklAlRUd6QuukzU3em7JhgjF8UH0-6--B_LhBTu_NLcHllSyVnnNOS07_UoCZoret9CkrPNur2qqxqJmRNRaY2_6HyMTBb7V12n_vPBj79MzCCmtIY_bSsLxqfg_gE6uBjDNC3-2BnFY4tJe2ajjano13T0a7pyPyHB1dLN4N5oh_jkIHPJyDu82da4-MTk5VwKTCpMBWy4n8AWezDWw</recordid><startdate>20160501</startdate><enddate>20160501</enddate><creator>NISHIMURA, YUKIO</creator><creator>HYUGA, SUMIKO</creator><creator>TAKIGUCHI, SOICHI</creator><creator>HYUGA, MASASHI</creator><creator>ITOH, KAZUYUKI</creator><creator>HANAWA, TOSHIHIKO</creator><general>D.A. Spandidos</general><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20160501</creationdate><title>Ephedrae herba stimulates hepatocyte growth factor-induced MET endocytosis and downregulation via early/late endocytic pathways in gefitinib-resistant human lung cancer cells</title><author>NISHIMURA, YUKIO ; HYUGA, SUMIKO ; TAKIGUCHI, SOICHI ; HYUGA, MASASHI ; ITOH, KAZUYUKI ; HANAWA, TOSHIHIKO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c556t-9839cf9d1a837fa091a358373395691e8c207c9112885137067f91a6bd4b28223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Antineoplastic Agents, Phytogenic - pharmacology</topic><topic>Breast cancer</topic><topic>Carcinoma, Non-Small-Cell Lung - metabolism</topic><topic>Care and treatment</topic><topic>Cell Line, Tumor</topic><topic>Down-Regulation - drug effects</topic><topic>Drug Resistance, Neoplasm - drug effects</topic><topic>endocytosis</topic><topic>Endocytosis - drug effects</topic><topic>endosomes/lysosomes</topic><topic>Ephedra</topic><topic>Ephedra - chemistry</topic><topic>Ephedrae herba</topic><topic>Gene amplification</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>Genetic aspects</topic><topic>Genetic regulation</topic><topic>Growth factors</topic><topic>Health aspects</topic><topic>hepatocyte growth factor</topic><topic>Hepatocyte Growth Factor - metabolism</topic><topic>Humans</topic><topic>Immunoglobulins</topic><topic>Inhibitor drugs</topic><topic>Kinases</topic><topic>Ligands</topic><topic>Lung cancer</topic><topic>Lung cancer, Non-small cell</topic><topic>Lung Neoplasms - metabolism</topic><topic>Materia medica, Vegetable</topic><topic>MET</topic><topic>Metastasis</topic><topic>Microscopy</topic><topic>Motility</topic><topic>non-small cell lung cancer</topic><topic>p-MET</topic><topic>Phosphorylation</topic><topic>Phosphorylation - drug effects</topic><topic>Plant extracts</topic><topic>Plant Extracts - pharmacology</topic><topic>Properties</topic><topic>Protein expression</topic><topic>Proteins</topic><topic>Proto-Oncogene Proteins c-met - metabolism</topic><topic>Quinazolines - pharmacology</topic><topic>Signal Transduction - drug effects</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NISHIMURA, YUKIO</creatorcontrib><creatorcontrib>HYUGA, SUMIKO</creatorcontrib><creatorcontrib>TAKIGUCHI, SOICHI</creatorcontrib><creatorcontrib>HYUGA, MASASHI</creatorcontrib><creatorcontrib>ITOH, KAZUYUKI</creatorcontrib><creatorcontrib>HANAWA, TOSHIHIKO</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>International journal of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NISHIMURA, YUKIO</au><au>HYUGA, SUMIKO</au><au>TAKIGUCHI, SOICHI</au><au>HYUGA, MASASHI</au><au>ITOH, KAZUYUKI</au><au>HANAWA, TOSHIHIKO</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ephedrae herba stimulates hepatocyte growth factor-induced MET endocytosis and downregulation via early/late endocytic pathways in gefitinib-resistant human lung cancer cells</atitle><jtitle>International journal of oncology</jtitle><addtitle>Int J Oncol</addtitle><date>2016-05-01</date><risdate>2016</risdate><volume>48</volume><issue>5</issue><spage>1895</spage><epage>1906</epage><pages>1895-1906</pages><issn>1019-6439</issn><eissn>1791-2423</eissn><abstract>The MET tyrosine kinase receptor and its ligand, hepatocyte growth factor (HGF), are known to be over-expressed in a variety of malignant tumor cells, and are implicated in the development of gefitinib-resistance in human non-small cell lung cancer (NSCLC) cells. Ephedrae herba was previously reported to prevent HGF-induced cancer cell motility by directly suppressing HGF/MET signaling through the inhibition of MET tyrosine kinase, and treatment with its extract also considerably reduced MET protein levels. To further investigate the mechanism underlying the Ephedrae herba-induced inhibition of MET phosphorylation as well as its degradation and subsequent disappearance, we examined the effect of Ephedrae herba on HGF-stimulated MET endocytosis and downregulation via early/late endocytic pathways in an NSCLC cell line. Using immunofluorescence microscopy, we found that pretreatment of cells with Ephedrae herba extract dramatically changed the intracellular distribution of plasma membrane-associated MET, and that the resultant MET staining was distributed throughout the cytoplasm. Pretreatment of the cells with Ephedrae herba extract also led to the rapid loss of MET and phosphorylated (p)-MET in HGF-stimulated cells. In contrast, inefficient endocytic delivery of MET and p-MET from early to late endosomes was observed in the absence of Ephedrae herba extract, since considerable amounts of the internalized MET accumulated in the early endosomes and were not delivered to lysosomes up to 1 h after HGF-stimulation. Furthermore, large amounts of MET and p-MET that had accumulated in late endosomes of Ephedrae herba-pretreated cells after HGF stimulation were observed along with bafilomycin A1. Therefore, we inferred that degradation of MET occurred in the late endosome/lysosome pathway. Moreover, western blot analysis revealed the accelerated degradation of MET and p-MET proceeds in cells pretreated with Ephedrae herba extract. Collectively, our results suggest that some components of Ephedrae herba have a novel role in promoting HGF-stimulated MET and p-MET endocytosis followed by its downregulation, likely mediated by the early/late endocytic pathways.</abstract><cop>Greece</cop><pub>D.A. Spandidos</pub><pmid>26983447</pmid><doi>10.3892/ijo.2016.3426</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1019-6439
ispartof International journal of oncology, 2016-05, Vol.48 (5), p.1895-1906
issn 1019-6439
1791-2423
language eng
recordid cdi_proquest_journals_1932331431
source Spandidos Publications Journals; MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Antineoplastic Agents, Phytogenic - pharmacology
Breast cancer
Carcinoma, Non-Small-Cell Lung - metabolism
Care and treatment
Cell Line, Tumor
Down-Regulation - drug effects
Drug Resistance, Neoplasm - drug effects
endocytosis
Endocytosis - drug effects
endosomes/lysosomes
Ephedra
Ephedra - chemistry
Ephedrae herba
Gene amplification
Gene expression
Gene Expression Regulation, Neoplastic - drug effects
Genetic aspects
Genetic regulation
Growth factors
Health aspects
hepatocyte growth factor
Hepatocyte Growth Factor - metabolism
Humans
Immunoglobulins
Inhibitor drugs
Kinases
Ligands
Lung cancer
Lung cancer, Non-small cell
Lung Neoplasms - metabolism
Materia medica, Vegetable
MET
Metastasis
Microscopy
Motility
non-small cell lung cancer
p-MET
Phosphorylation
Phosphorylation - drug effects
Plant extracts
Plant Extracts - pharmacology
Properties
Protein expression
Proteins
Proto-Oncogene Proteins c-met - metabolism
Quinazolines - pharmacology
Signal Transduction - drug effects
Studies
title Ephedrae herba stimulates hepatocyte growth factor-induced MET endocytosis and downregulation via early/late endocytic pathways in gefitinib-resistant human lung cancer cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T12%3A30%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ephedrae%20herba%20stimulates%20hepatocyte%20growth%20factor-induced%20MET%20endocytosis%20and%20downregulation%20via%20early/late%20endocytic%20pathways%20in%20gefitinib-resistant%20human%20lung%20cancer%20cells&rft.jtitle=International%20journal%20of%20oncology&rft.au=NISHIMURA,%20YUKIO&rft.date=2016-05-01&rft.volume=48&rft.issue=5&rft.spage=1895&rft.epage=1906&rft.pages=1895-1906&rft.issn=1019-6439&rft.eissn=1791-2423&rft_id=info:doi/10.3892/ijo.2016.3426&rft_dat=%3Cgale_proqu%3EA456289618%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1932331431&rft_id=info:pmid/26983447&rft_galeid=A456289618&rfr_iscdi=true